News Center
Chongqing Saintsun Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Lunarsun Pharmaceutical, has officially obtained the Drug Registration Certificate for its developed product Sodium Thiosulfate Injection on June 30, 2026..
Approval Number: 国药准字H20265042
This drug is a first-line clinical emergency antidote, which is routinely stocked in hospitals, so it has a steady market demand.
We sincerely welcome inquiries and cooperation opportunities.
Copyright(C)2024,Beijing Lunarsun Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle 31fabu Copyright Notice